Clinical trial
Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage…
NCT00216151 · Hoosier Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00216151 |
|---|---|
| Title | Zoledronic Acid in the Management of Patients With Asymptomatic/Early Stage Multiple Myeloma |
| Official title | A Randomized Phase II Study of Bisphosphonate: Zoledronic Acid (Zometa) in the Management of Asymptomatic/Early Stage Multiple Myeloma: Hoosier Oncology Group MM02-35 |
| Lead sponsor | Hoosier Cancer Research Network, Other |
| Collaborators | Novartis Pharmaceuticals Industry Walther Cancer Institute |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Zoledronic Acid |
| Enrollment | 3 |
| Start date | Jun 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | May 2, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: